In response to the ongoing trade disputes, Japan has imposed a hefty tariff of up to 100% on American imported pharmaceutical products. This move, a significant upturn in the international trade landscape, sends a clear message from Tokyo to Washington D.C regarding their mutual trade policies. Critics worry about the impact on the availability of essential medicines in Japan, while others argue it might boost the domestic pharmaceutical industry.

Healthcare is a crucial part of Japanese society, providing world-leading medical services to its ageing population. This tariff could potentially disrupt the supply of medicines and raise healthcare costs. However, some believe it's a chance to invigorate Japan's own pharmaceutical industry to ensure a steady supply of domestically produced medicines.

Trade disputes and the implementation of retaliatory tariffs are not uncommon in the international arena. The US, for example, has imposed tariffs on goods imported from various nations, including China and the EU, previously. While these tactics are generally viewed as a part of hard-nosed negotiations, the consequences often impact various sectors, including healthcare, affecting the common people the most.